Published in Hepatology on July 01, 1995
Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding (Early TIPSS) | NCT02377141
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Improving prognosis following a first variceal haemorrhage over four decades. Gut (2001) 2.14
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Updates in the pathogenesis, diagnosis and management of ectopic varices. Hepatol Int (2008) 1.97
Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol (2007) 1.59
Transabdominal modified devascularization procedure with or without esophageal stapler transection--an operation adequate for effective control of a variceal bleed. Is esophageal stapler transection necessary? World J Surg (2006) 1.42
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int (2007) 1.24
The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg (2005) 1.21
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc (2008) 1.17
Hand-assisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J Surg (2006) 1.12
Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10
Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol (2007) 1.07
Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol (2013) 1.05
Modern management of oesophageal varices. Postgrad Med J (2001) 1.03
Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol (2014) 1.00
Current state of portosystemic shunt surgery. Langenbecks Arch Surg (2003) 0.98
Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899]. BMC Gastroenterol (2003) 0.98
Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int (2008) 0.96
Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci (2008) 0.95
Emergency management of bleeding esophageal varices: drugs, bands or sleep? Can J Gastroenterol (2006) 0.92
An assessment of endoscopic and concomitant management of acute variceal bleeding at a tertiary care centre. Can J Gastroenterol (2007) 0.91
Adherence and adequacy of therapy for esophageal varices prophylaxis. Dig Dis Sci (2011) 0.90
Beta-blockers in liver cirrhosis. Ann Gastroenterol (2014) 0.90
Management of portal hypertension. Postgrad Med J (2004) 0.90
Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg (2006) 0.89
Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a swiss multicentric cohort. Case Rep Gastroenterol (2013) 0.89
Management of portal hypertension in children. Curr Gastroenterol Rep (2011) 0.88
Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87
Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl (2009) 0.87
Endoscopic management of gastric variceal bleeding with cyanoacrylate glue injection: safety and efficacy in a Canadian population. Can J Gastroenterol (2010) 0.87
Long-term results with the modified Sugiura procedure for the management of variceal bleeding: standing the test of time in the treatment of bleeding esophageal varices. World J Surg (2012) 0.87
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci (2005) 0.87
The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol (2009) 0.86
Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis. World J Hepatol (2014) 0.86
Self-expandable metal stents in the treatment of acute esophageal variceal bleeding. Gastroenterol Res Pract (2011) 0.86
Duplex Doppler ultrasound examination of the portal venous system: an emerging novel technique for the estimation of portal vein pressure. Dig Dis Sci (2009) 0.86
Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon's Point of View. Viszeralmedizin (2014) 0.86
507 Warren-Zeppa distal splenorenal shunts: a 34-year experience. Ann Surg (2006) 0.86
Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci (2008) 0.86
Management of portal hypertension in children. World J Gastroenterol (2012) 0.85
Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis (2009) 0.85
Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol (2011) 0.85
Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol (2011) 0.84
Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr (2011) 0.84
Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol (2011) 0.84
Bleeding duodenal varices successfully treated with TIPS. Dig Dis Sci (2006) 0.83
A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci (2005) 0.83
Changes in the clinical outcomes of variceal bleeding in cirrhotic patients: a 10-year experience in gangwon province, South Korea. Gut Liver (2012) 0.83
Esophageal capsule endoscopy. World J Gastroenterol (2008) 0.83
Does gastroesophageal reflux have an influence on bleeding from esophageal varices? J Gastroenterol (2008) 0.83
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Self-Expanding Metal Stent (SEMS): an innovative rescue therapy for refractory acute variceal bleeding. Endosc Int Open (2014) 0.82
Evolution of endoscopic therapy for esophageal varices. Surg Endosc (2006) 0.82
Transjugular portosystemic stent shunt in treatment of liver diseases. World J Gastroenterol (2001) 0.81
High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT. Dig Dis Sci (2008) 0.81
Acute variceal bleeding: general management. World J Gastroenterol (2001) 0.81
Role of self-expandable metal stents in acute variceal bleeding. Int J Hepatol (2012) 0.81
Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc (2010) 0.81
Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma. Dig Dis Sci (2002) 0.81
The risk factors for bleeding of fundal varices in patients with liver cirrhosis. Gut Liver (2013) 0.81
Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci (1997) 0.81
New index to predict esophageal variceal bleeding in cirrhotic patients. World J Gastroenterol (2014) 0.80
Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci (1998) 0.80
Endoscopic ultrasound guided vascular access and therapy (with videos). Endosc Ultrasound (2015) 0.80
Current research of hepatic cirrhosis in China. World J Gastroenterol (2005) 0.79
Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol (2014) 0.79
Multidetector computed tomography for preoperative assessment of hepatic vasculature and prediction of splenic artery steal syndrome in patients with liver cirrhosis before transplantation. Eur Radiol (2009) 0.79
Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis. J Gastroenterol (2012) 0.78
Microwave coagulation versus sclerotherapy after band ligation to prevent recurrence of high risk of bleeding esophageal varices in Child-Pugh's A and B patients. J Gastroenterol (2009) 0.78
Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. J Gastrointest Surg (2010) 0.78
Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding. Korean J Intern Med (2000) 0.78
Prevention and management of variceal hemorrhage. Int J Hepatol (2013) 0.78
A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls. PLoS One (2014) 0.78
When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS? Langenbecks Arch Surg (2003) 0.78
Combined liver and kidney transplantation in children. Pediatr Nephrol (2013) 0.78
The Child-Turcotte Classification: From Gestalt to Sophisticated Statistics and Back. Dig Dis Sci (2016) 0.78
Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease. World J Gastroenterol (2008) 0.77
Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats. Dig Dis Sci (1998) 0.77
Recent advances in cirrhotic cardiomyopathy. Dig Dis Sci (2014) 0.77
Long-term results of the paraesophagogastric devascularization with or without esophageal transection: which is more suitable for variceal bleeding? World J Surg (2014) 0.77
Severe bleeding from esophageal varices resistant to endoscopic treatment in a non cirrhotic patient with portal hypertension. World J Emerg Surg (2008) 0.77
Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices. World J Surg (2015) 0.77
Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76
Current Management of Esophageal Varices. Curr Treat Options Gastroenterol (2003) 0.76
Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review. Ann Med (2013) 0.76
Liver: Early TIPS in patients with cirrhosis and variceal bleeding. Nat Rev Gastroenterol Hepatol (2010) 0.76
TIPS for gastric varices. Gut (2003) 0.76
Endoscopic management of portal hypertension. Int J Hepatol (2012) 0.76
Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc (2002) 0.76
Etiology of Portal Hypertension in Children:A Single Center's Experiences. Middle East J Dig Dis (2012) 0.76
Ectopic varices and collaterals development after band ligation treatment in a patient with portal hypertension. Case Rep Gastroenterol (2008) 0.75
Post-gastrectomy spleen enlargement and esophageal varices: distal vs total gastrectomy. World J Gastroenterol (2010) 0.75
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib. United European Gastroenterol J (2015) 0.75
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med (2001) 6.38
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet (1995) 6.06
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation (2001) 3.96
Health services: an Italian market. Lancet (1996) 3.43
Ramipril and the development of diabetes. JAMA (2001) 3.38
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol (2001) 2.93
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76
Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology (2000) 2.57
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation (2001) 2.30
Smoking habits and recurrence in Crohn's disease. Gastroenterology (1994) 2.30
Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis (1999) 2.15
Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci (1991) 2.12
Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology (1998) 2.10
Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci (1986) 2.07
Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 2.02
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology (1989) 1.97
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J (2004) 1.90
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet (1991) 1.88
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology (1998) 1.87
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology (1987) 1.77
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology (1988) 1.74
Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension. Hepatology (1983) 1.67
Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology (2000) 1.67
Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology (1993) 1.67
Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology (1999) 1.64
Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology (1996) 1.64
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology (2001) 1.62
Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology (1999) 1.62
Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol (1999) 1.60
The lung in patients with cirrhosis. J Hepatol (1990) 1.59
Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology (1992) 1.57
Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol (1998) 1.55
Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology (1988) 1.53
Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol (1991) 1.52
Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology (1983) 1.49
Testing non-linearity and directedness of interactions between neural groups in the macaque inferotemporal cortex. J Neurosci Methods (1999) 1.49
Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension. Gastroenterology (1998) 1.47
Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology (1992) 1.45
Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am J Physiol (1992) 1.43
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut (2008) 1.43
TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology (1999) 1.42
Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan. J Invasive Cardiol (2000) 1.41
Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40
Urate levels as a predictor of cardiac deaths: causal relation or mere association? Eur Heart J (2002) 1.40
Oral administration of clonidine in patients with alcoholic cirrhosis. Hemodynamic and liver function effects. Gastroenterology (1992) 1.40
Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol (1991) 1.40
[Terlipressin in the treatment of portal hypertension]. Gastroenterol Hepatol (1998) 1.39
[Epidemiology of head traumas. "Barcelona" data base. Objectives, design and analysis of 584 cases]. Rev Esp Anestesiol Reanim (1992) 1.38
Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology (1984) 1.36
The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants. J Biol Chem (1996) 1.32
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother (1986) 1.32
Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology (2001) 1.29
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology (2001) 1.28
Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther (1999) 1.28
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Antibiotic resistance of Streptococcus pneumoniae in childhood carriers. J Antimicrob Chemother (1987) 1.26
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology (1981) 1.25
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. Can J Cardiol (1998) 1.22
Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem (1991) 1.20
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Hepatitis C virus and Sjögren's syndrome. Lancet (1992) 1.19
Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis (1987) 1.17
Developing and establishing bee species as crop pollinators: the example of Osmia spp. (Hymenoptera: Megachilidae) and fruit trees. Bull Entomol Res (2002) 1.17
Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone (1995) 1.17
Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci (1999) 1.16
Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother (1986) 1.16
Long-term course of interferon-treated chronic hepatitis C. J Hepatol (1998) 1.15
High survival rate of 43% in out-of-hospital cardiac arrest patients in an optimised chain of survival. Neth Heart J (2015) 1.15
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study. Clin Nephrol (2005) 1.15
Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology (1980) 1.14
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol (1992) 1.14
Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology (1998) 1.14
Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol (1992) 1.13
Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology (1991) 1.13
CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J Immunol (2001) 1.13
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients. Cancer (1985) 1.12
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology (1999) 1.12
Family functioning and psychosocial adjustment in overweight youngsters. Int J Eat Disord (2000) 1.12
Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci (1983) 1.12
Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis (1986) 1.12
Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology (1990) 1.11
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia (2011) 1.10
Pseudocysts in acute nonalcoholic pancreatitis: incidence and natural history. Dig Dis Sci (1999) 1.10
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J (2010) 1.10
Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology (1985) 1.09
Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension. Gut (2008) 1.09